
Guangyu Biomedical
光域生物
Guangyu Biomedical
Biotech/Healthcare
Guangyu Biomedicine's core technology is in vivo flow cytometry (IVFC), an internationally pioneering technology with independent intellectual property rights. Based on IVFC, it enables blood-draw-free, real-time, dynamic, continuous, non-invasive, and quantitative detection and monitoring of…
Latest round: Strategic (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-06-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.